These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15008996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys.
    Brosnihan KB, Weddle D, Anthony MS, Heise C, Li P, Ferrario CM.
    J Hypertens; 1997 Jul; 15(7):719-26. PubMed ID: 9222939
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Brown NJ, Abbas A, Byrne D, Schoenhard JA, Vaughan DE.
    Circulation; 2002 Jan 22; 105(3):304-9. PubMed ID: 11804984
    [Abstract] [Full Text] [Related]

  • 11. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD, Brosnihan KB, Herrington DM.
    Minerva Cardioangiol; 2007 Aug 22; 55(4):477-85. PubMed ID: 17653023
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H, Ichikawa S, Miya Y, Sakamaki T, Kurabayashi M.
    Am J Hypertens; 2005 Oct 22; 18(10):1340-6. PubMed ID: 16202859
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH.
    Am J Hypertens; 1999 May 22; 12(5):451-9. PubMed ID: 10342782
    [Abstract] [Full Text] [Related]

  • 15. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M, Ichikawa S, Kanda T, Sumino H, Kobayashi I.
    Am J Hypertens; 2001 Mar 22; 14(3):206-11. PubMed ID: 11281230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.